News Conference News AHA 2017 More Support for TMVR After Failed Mitral Bioprostheses Yael L. Maxwell November 23, 2017
News Conference News AHA 2017 Continuing NOACs During Device Surgery Does Not Reduce Pocket Hematoma Todd Neale November 15, 2017
News Conference News AHA 2017 Low-Dose Rivaroxaban Plus Aspirin Lowers Some Costs in COMPASS, but Full Economic Impact Unclear Todd Neale November 14, 2017
News Conference News TCT 2017 Valve-in-Ring, Valve-in-MAC TMVR Procedures Feasible, but Patient Selection Is Key Yael L. Maxwell November 10, 2017
News Conference News TCT 2017 TAVR Beats Out SAVR, at Least In-Hospital, for Patients With Prior CABG Ashley Lyles November 08, 2017
News Conference News TCT 2017 For ‘Torrential’ Tricuspid Regurgitation, Two New Transcatheter Devices Safe, Effective in Early Results Yael L. Maxwell November 02, 2017
News Conference News TCT 2017 One in Six Patients With LBBB Post-TAVR Develop Atrioventricular Block Michael O'Riordan October 31, 2017
News Conference News PCR London Valves 2017 CT Scans Before and After TAVR Show Tricuspid, Bicuspid Valves Are Reassuringly Similar Shelley Wood September 28, 2017
News Conference News PCR London Valves 2017 Pacemakers and Paravalvular Leak With Lotus: Updates From REPRISE III Shelley Wood September 27, 2017
News Conference News PCR London Valves 2017 As Percutaneous Mitral Valve Techniques Advance, Questions Turn to Combinations, Staging Shelley Wood September 26, 2017
News Conference News PCR London Valves 2017 TAVR Takeover? Experts Debate Timing of Surgery’s Ousting in Aortic Stenosis Shelley Wood September 24, 2017
News Conference News TVT 2017 Merits of Minimalist TAVR: Patient Satisfaction and a Better Bottom Line Michael O'Riordan June 20, 2017
News Conference News TVT 2017 Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial Shelley Wood June 16, 2017
News Conference News TVT 2017 Q&A: Transcatheter Valve Innovation Past, Present, and Future as TVT Turns 10 Shelley Wood June 12, 2017
News Conference News EuroPCR 2017 TAVR Durability: Some Reassurances From CoreValve Trials Out to 9 Years Caitlin E. Cox May 17, 2017
News Conference News EuroPCR 2017 Bicuspid AS Patients with Calcification Fare Worse After TAVR, But Device Type Matters Michael O'Riordan May 17, 2017
News Conference News EuroPCR 2017 REPRISE III: Lotus Valve Matches CoreValve in First, Large Head-to-Head TAVR Trial Shelley Wood May 16, 2017
News Conference News ACC 2017 TAVR for Bicuspid Aortic Stenosis? Registry Offers Clues to Safety, Outcomes Shelley Wood March 24, 2017